RESUMO
Accurate pathologic evaluation is essential for proper diagnosis and treatment of patients with cancer. ASCO and the College of American Pathologists have successfully collaborated over the last 15 years to improve collaboration between clinical oncologists and pathologists and to standardize pathologic assay techniques. Cancer is an increasingly recognized societal burden in low- and middle-income countries. In 2015, ASCO and the College of American Pathologists implemented an initiative to identify countries that could benefit from peer insights by jointly convening an international workshop among members of both organizations and pathologists and clinical oncologists from Haiti, Honduras, Vietnam, and Uganda. Honduras was chosen as a pilot site, and representatives of ASCO, the College of American Pathologists, and the Honduras pathology and clinical oncology communities have identified areas in which collaboration might be productive. Multiple barriers, including high poverty levels, poor cancer awareness educational programs, lack of human resources, and delayed diagnosis and treatment, have resulted in a higher cancer mortality rate in Honduras compared with high/moderate-income countries and are shared by other low-income countries. ASCO and the College of American Pathologists member faculty supported a symposium led by Honduras colleagues for interested Honduran pathologists and oncologists. The Honduran communities are now working to establish national resource-appropriate guidelines for both pathology and clinical oncology. Taken together, these efforts indicate that barriers to meet the needs of the clinical oncologists in a low-income country such as Honduras are challenging but not insurmountable.
Assuntos
Neoplasias , Patologistas , Humanos , Oncologia , Neoplasias/diagnóstico , Neoplasias/epidemiologia , Neoplasias/terapia , Estados Unidos/epidemiologiaRESUMO
La implementación deprocedimientos de donación y trasplante de órganos requiere de habilidades médicas y quirúrgicas que han sido ampliamente desarrolladas desde el siglo pasado y que se hanconsolidado en el presente. Sin embargo, se requiere que los países que ven éstos como la oportunidad de prolongar la vida de sus habitantes con enfermedades graves y sin otra opción terapéutica, hagan consideraciones bioéticas que garanticen el respeto a los deberes y derechos propios de la dignidad humana de todos los involucrados, con el fin de evitar violación de derechos humanos universales y garantizar el éxito clínico...(AU)